Effect of Dignity Therapy on Distress and End-of-Life Experience in Terminally Ill Patients: A Randomised Controlled Trial
Abstract
Background
Dignity therapy is a unique, individualised, short-term psychotherapy that was developed for patients (and their families) living with life-threatening or life-limiting illness. We investigated whether dignity therapy could mitigate distress or bolster the experience in patients nearing the end of their lives.
Methods
Patients (aged ≥18 years) with a terminal prognosis (life expectancy ≤6 months) who were receiving palliative care in a hospital or community setting (hospice or home) in Canada, USA, and Australia were randomly assigned to dignity therapy, client-centred care, or standard palliative care in a 1:1:1 ratio. Randomisation was by use of a computer-generated table of random numbers in blocks of 30. Allocation concealment was by use of opaque sealed envelopes. The primary outcomes—reductions in various dimensions of distress before and after completion of the study—were measured with the Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Scale, Patient Dignity Inventory, Hospital Anxiety and Depression Scale, items from the Structured Interview for Symptoms and Concerns, Quality of Life Scale, and modified Edmonton Symptom Assessment Scale. Secondary outcomes of self-reported end-of-life experiences were assessed in a survey that was undertaken after the completion of the study. Outcomes were assessed by research staff with whom the participant had no previous contact to avoid any possible response bias or contamination. Analyses were done on all patients with available data at baseline and at the end of the study intervention. This study is registered with ClinicalTrials.gov, number NCT00133965.
Findings
165 of 441 patients were assigned to dignity therapy, 140 standard palliative care, and 136 client-centred care. 108, 111, and 107 patients, respectively, were analysed. No significant differences were noted in the distress levels before and after completion of the study in the three groups. For the secondary outcomes, patients reported that dignity therapy was significantly more likely than the other two interventions to have been helpful (χ2=35·50, df=2; p<0·0001), improve quality of life (χ2=14·52; p=0·001), increase sense of dignity (χ2=12·66; p=0·002), change how their family saw and appreciated them (χ2=33·81; p<0·0001), and be helpful to their family (χ2=33·86; p<0·0001). Dignity therapy was significantly better than client-centred care in improving spiritual wellbeing (χ2=10⋅35; p=0 ⋅ 006), and was significantly better than standard palliative care in terms of lessening sadness or depression (χ2=9⋅38; p=0⋅009); significantly more patients who had received dignity therapy reported that the study group had been satisfactory, compared with those who received standard palliative care (χ2=29⋅58; p<0·0001).
Interpretation
Although the ability of dignity therapy to mitigate outright distress, such as depression, desire for death or suicidality, has yet to be proven, its benefits in terms of self-reported end-of-life experiences support its clinical application for patients nearing death.
Funding
National Cancer Institute, National Institutes of Health.
(Reprinted with permission from The Lancet Oncology 2011;12:753–762)
Introduction
Research into methods to understand and support patients who are nearing the end of their lives is increasing.1–3 Dignity therapy, a unique, individualised, brief psychotherapy, was developed for the purpose of relieving distress and enhancing the end-of-life experiences of terminally ill patients. It provides these patients with an opportunity to reflect on things that matter most to them or that they would most want remembered. The therapeutic process begins with a framework of questions (panel 1) that are based on an empirical model of dignity in the terminally ill patient.4,5 These conversations, guided by a trained therapist, are flexible to accommodate the patients’ needs and choices about what they specifically wish to address. Dignity therapy is audiorecorded and transcribed, with an edited version of the transcript given to patients to share or bequeath to individuals of their choice.
Panel 1: Protocol for questions about dignity therapy
•.
Tell me a little about your life history, particularly the parts that you either remember most or think are the most important? When did you feel most alive?
•.
Are there specific things that you would want your family to know about you, and are there particular things you would want them to remember?
•.
What are the most important roles you have had in life (eg, family roles, vocational roles, community-service roles)? Why were they so important to you and what do you think you accomplished in those roles?
•.
What are your most important accomplishments, and what do you feel most proud of?
•.
Are there particular things that you feel still need to be said to your loved ones or things that you would want to take the time to say once again?
•.
What are your hopes and dreams for your loved ones?
•.
What have you learned about life that you would want to pass along to others? What advice or words of guidance would you wish to pass along to your son, daughter, husband, wife, parents, or other(s)?
•.
Are there words or perhaps even instructions that you would like to offer your family to help prepare them for the future?
•.
In creating this permanent record, are there other things that you would like included?
In a phase 1 trial with 100 terminally ill patients, 91% were satisfied with dignity therapy, and 76% reported a heightened sense of dignity, 68% an increased sense of purpose, 67% a heightened sense of meaning, 47% an increased will to live, and 81% that it had been or would be of help to their family.6 Post-intervention assessments of suffering and depressive symptoms showed small, but significant improvements.6 78% of patients’ family members reported that the therapy enhanced the patient’s dignity, and 72% that it heightened the meaning of life for the patient; 78% said the document from the therapy session was a comfort to them in their time of grief, and 95% that they would recommend dignity therapy to other patients and their families.7 We therefore investigated whether this novel psychotherapeutic approach would be better than standard palliative care and client-centred care (which focused on non-generativity—ie, here and now issues) in terms of reducing psychological, existential, and spiritual distress in patients who are terminally ill.
Methods
Participants
Individuals were eligible for participation in the study if they had a terminal prognosis with a life expectancy of 6 months or less, according to their treating physician; were receiving palliative care in a hospital or community setting (hospice or home) through an affiliated recruitment site in Canada, USA, and Australia; were aged 18 years or older; were willing to commit to three or four contacts over about 7–10 days; and were able and willing to provide written informed consent. Patients were excluded if they were delirious or otherwise cognitively impaired (based on clinical consensus and post-randomisation Blessed Orientation Memory Concentration test),8 too ill to complete the requirements of the protocol, or unable to speak and read English.
This trial was coordinated by the Manitoba Palliative Care Research Unit at CancerCare Manitoba, Winnipeg, MB, Canada. Other participating centres were Curtin University, Perth, WB, Australia, and Memorial Sloan Kettering Cancer Center, New York, NY, USA. Approval was obtained from the ethics committees of all participating centres. All participants provided written informed consent.
Randomisation and Masking
After providing consent, all participants were randomly assigned in a 1:1:1 ratio to one of three study groups— dignity therapy, standard palliative care, or client-centred care—and asked to complete baseline psychosocial questionnaires. The study statistician used a computer-generated table of random numbers in blocks of 30 to allocate patients. Allocation concealment was by use of opaque sealed envelopes. The envelopes were sent to each site and opened sequentially by study staff after consent had been obtained from the patient. To avoid any possible response bias or contamination, research staff with whom the participant had no previous contact administered the final psychometric battery of questionnaires. Recordings from the dignity therapy and client-centred care groups were reviewed by the study coordinator to ensure protocol adherence and prevent cross-contamination.
Study Groups
Dignity therapy was provided by a psychologist, psychiatrist, or experienced palliative-care nurse. All therapists took part in a 3-day training workshop, led by the principal investigator (HMC). Continuous supervision of the therapy was provided by the site investigator (HMC, LJK, WB), initially for every case and then varied, until each therapist was fully competent. Group supervision, led by the principal investigator, took place every 6–8 weeks throughout the study, with videoconferencing to connect all three study sites. The principal investigator also reviewed a random sample (about one in six) of transcripts from all study sites to identify any difficulties or therapeutic improvements. Feedback from this review was offered either individually or, when more broadly applicable, within group supervision.
Patients were shown the framework of questions for dignity therapy (panel 1) and asked to consider what they might wish to speak about during their session(s); this initial introduction to, and explanation of, dignity therapy took about 30 min. Within a few days, or as soon as a second meeting could be arranged, the therapist used the question framework to help elicit patients’ recollections, hopes, wishes for loved ones, lessons learned, and things they wanted remembered by those they were about to leave behind. Dignity therapy is flexible enough to accommodate participant’s preferences and choices about content, but the ethos of questioning targets those things that might enhance a sense of meaning, purpose, continued sense of self, and overall sense of dignity. All therapy sessions were audiotaped; these sessions usually took about 60 min. On completion, the audiorecording was transcribed verbatim and the transcript edited, to provide a clear and readable narrative. This transcript or generativity document was returned to the patient within about 4 working days from their previous session, read to them in its entirety to ensure that no errors of omission or commission needed to be addressed (this final session usually took about 30 min). The final version of the generativity document was given to the patient, to be passed along to a recipient of the patient’s choice, from whom follow-up data were later obtained (the effect of dignity therapy on family members given the generativity documents will be reported separately). At the conclusion of this session, participants were asked to complete a psychometric follow-up battery described in the outcome measurements section below. [Generativity or the ability to guide the next generation, encompasses how patients might fi nd strength or comfort in knowing that they will leave behind something lasting and transcendent after death]
Client-centred care is a supportive psychotherapeutic approach, in which the research nurse therapist guides the patient through discussions that focus on here-and-now issues—ie, participants are asked about their illness, associated symptoms, and what is being done to address their distress. The content of client-centred care was kept as distinct from dignity therapy as much as possible and did not focus on issues of generativity, meaning, or purpose. If these issues were raised, the therapist did not probe for additional detail, allowing the interview to gently return to illness-related inquiry. Although these sessions were audiorecorded for purposes of auditing protocol adherence, no permanent record of these conversations was provided to the patient or the patient’s family. The number of contacts for client-centred care and dignity therapy were identical, with the initial, middle, and final meetings designed to take about the same time in both groups. During the final meeting, 7–10 days later, the participants completed the psychometric battery.
Participants assigned to standard palliative care had access to the complete range of palliative-care-support services that were available to all study patients, including specialist palliative-care physicians and nurses (ie, experts in the management of pain and symptoms), social workers, chaplains, and psychologists or psychiatrists. No participating site provided a formal approach to addressing generativity issues; therefore, a programme similar to dignity therapy was not available to patients who were not randomly assigned to this group. Patients were asked to complete the battery of psychometric questionnaires as soon as they were assigned to standard palliative care and then 7–10 days later—a timeframe roughly corresponding to the time between the first and last contact in the other two study groups.
Outcome Measurements
The primary outcomes—reductions in various dimensions of distress—consisted of mean changes between baseline and end of intervention in measurements of psychosocial, spiritual, and existential distress. The primary measurements were the Palliative Performance Scale (for physical performance; 100%=healthy, 0%=death),9 Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Scale (spiritual wellbeing with two subscales— meaning or peace and faith),10 Patient Dignity Inventory,11 and Hospital Anxiety and Depression Scale.12 We also administered items from the Structured Interview for Symptoms and Concerns,13 including dignity, desire for death, suffering, hopelessness, depression, suicidal ideation, and sense of burden to others. Additional measurements were a two-item Quality of Life Scale14 and an Edmonton Symptom Assessment Scale, modified to include a will-to-live visual analogue scale.15 All scales were administered at baseline and immediately after study completion. Secondary outcomes, addressing to what extent the intervention might have affected the participants’ end-of-life experiences, were measured with a survey done after study completion, with detailed questions about their experience of participation in the study and how it had affected them and their family (for the questionnaire see webappendix pp 1–18).
Statistical Analysis
Analyses were done on all patients with available data at baseline and at the end of the study intervention. The data were summarised with standard descriptive measurements. Two group comparisons were undertaken—t tests when the data approximated a normal distribution and Mann Whitney U tests when the data were ordinal. Three group comparisons were undertaken by use of ANOVA when a normal distribution was reasonably approximated and Kruskal-Wallis tests when it was not. With an α set at 0·05, desired power set at 80%, and small-to-medium effect size with Cohen’s value for such an effect size of 0·15, the estimated recruitment target was 120 patients per group.16 The effect size here refers to the standard deviation of the group means divided by the postulated common standard deviation. With three groups, an effect size of 0⋅15 would imply that at least one group mean is at least a third of a standard deviation away from the other two. SPSS (version 18.0) was used for the statistical analysis.
When a significant result was obtained in a multigroup comparison, the precise nature of the group differences was investigated with Tukey’s test (if ANOVA had been used) or a series of Mann-Whitney U tests (if the Kruskal-Wallis test had been used). Comparisons of before and after therapy were undertaken by use of the paired t test if the data were roughly normal or the Wilcox signed-rank test if they were not. All comparisons were done on a two-tailed basis. Since the number of comparisons was large and the risk of type 1 errors was increased, a probability of less than 0·01 was prespecified as the minimum acceptable designation of significance.
This study is registered with ClinicalTrials.gov, number NCT00133965.
Role of the Funding Source
The funders had no role in the study design, data collection, analysis or interpretation of the data, or in writing the final report. The corresponding author had full access to all the data and final responsibility to submit for publication.
Results
The figure shows the trial profile. 1513 patients were assessed for eligibility by use of a consecutive sampling approach between April, 2005, and October, 2008. After randomisation, 28 patients died, 85 withdrew because of declining health, and two failed Blessed Orientation Memory Concentration screening. These individuals were excluded from the analysis because we had either no or only incomplete data for them. Therefore, 326 participants—108 (33%) assigned to dignity therapy, 111 (34%) to standard palliative care, and 107 (33%) to client-centred care—completed the study. Recruitment was fairly even across the three study sites (Winnipeg [n=119], Perth [n=99], and New York [n=108]), with the number of participants at each site balanced across the study groups.
Table 1 shows that the baseline demographic characteristics of participants assigned to the three groups were well balanced. 161 (49%) of 326 participants were men (table 1). The mean age of the participants was 65⋅1 years (SD 14⋅4; range 22–102). 192 (59%) participants were married or living in common-law partnerships, and the rest were widowed, divorced, or not married. 138 (42%) were living with their spouse or partner, 86 (26%) were living alone, 70 (21%) were living with children, and the rest were living with others, such as friends or other relatives. 196 (60%) were receiving home-based palliative care, 72 (22%) palliative care in an inpatient unit, 31 (10%) acute care in an inpatient unit (followed by palliative care on a non-palliative-care unit), and 27 (8%) freestanding hospice care. 68 (21%) participants were Protestant, 86 (26%) Catholic, 43 (13%) Jewish, 51 (16%) Anglican, 43 (13%) other, 33 (10%) no religious affiliation, and two individuals did not provide an answer to the question about religious affiliation. 30 (9%) individuals had less than high school education, 107 (33%) had completed high school, and 188 (58%) had completed college or postgraduate training (one individual was unable to answer). Cancer sites were gastrointestinal (108 [33%]), genitourinary (26 [8%]), lung (48 [15%]), breast (29 [9%]), gynaecological (11 [3%]), miscellaneous solid tumours (67 [21%]), haematological (14 [4%]), and brain (nine [3%]), and 12 [4%] patients had non-malignant terminal illness (ie, end-stage organ failure and amyotrophic lateral sclerosis). The mean Palliative Performance Scale rating for all participants at baseline was 44⋅3% (SD 15⋅1).
| Dignity therapy (n=108) | Standard palliative care (n=111) | Client-centred care (n=107) | |
|---|---|---|---|
| Age (years) | 64·2 (14·6) | 66·7 (14·2) | 64·3 (14·3) |
| PPS score | 44·2 (15·2) | 44·2 (15·9) | 44·4 (14·4) |
| Sex (male) | 56 (52%) | 50 (45%) | 55 (51%) |
| Marital status | |||
| Married | 60 (56%) | 65 (59%) | 67 (63%) |
| Other | 48 (44%) | 46 (41%) | 40 (37%) |
| Religion* | |||
| Catholic | 31 (29%) | 26 (23%) | 29 (27%) |
| Protestant | 22 (20%) | 30 (27%) | 16 (15%) |
| Jewish | 17 (16%) | 11 (10%) | 15 (14%) |
| Anglican | 17 (16%) | 16 (14%) | 18 (17%) |
| Other | 11 (10%) | 18 (16%) | 14 (13%) |
| None | 9 (8%) | 10 (9%) | 14 (13%) |
| Living arrangements | |||
| Alone | 30 (28%) | 29 (26%) | 27 (25%) |
| Spouse | 37 (34%) | 50 (45%) | 51 (48%) |
| Others | 18 (17%) | 21 (19%) | 13 (12%) |
| Combination | 23 (21%) | 11 (10%) | 16 (15%) |
| Education | |||
| None or primary | 11 (10%) | 11 (10%) | 8 (7%) |
| High school | 38 (35%) | 36 (32%) | 33 (31%) |
| College | 43 (40%) | 47 (42%) | 45 (42%) |
| Postgraduate | 16 (15%) | 17 (15%) | 20 (19%) |
| Terminal illness | |||
| Primary cancer site | |||
| Lung | 15 (14%) | 15 (14%) | 18 (17%) |
| Breast | 10 (9%) | 8 (7%) | 11 (10%) |
| Gastrointestinal | 30 (28%) | 48 (43%) | 29 (27%) |
| Genitourinary | 12 (11%) | 9 (8%) | 8 (2%) |
| Gynaecological | 3 (3%) | 3 (3%) | 5 (5%) |
| Haematological | 5 (5%) | 6 (5%) | 3 (3%) |
| Brain | 4 (4%) | 2 (2%) | 3 (3%) |
| Other solid tumours | 23 (21%) | 20 (18%) | 24 (22%) |
| Non-malignant | 5 (5%) | 2 (2%) | 5 (5%) |
| Missing | 1 (<1%) | 1 (<1%) | 1 (<1%) |
| Ethnic origin | |||
| White | 98 (91%) | 99 (89%) | 94 (88%) |
| Other | 10 (9%) | 12 (11%) | 13 (12%) |
| Care setting | |||
| Palliative care unit | 25 (23%) | 21 (22%) | 24 (22%) |
| Inpatient palliative care service | 7 (6%) | 9 (9%) | 13 (12%) |
| Outpatient or home | 64 (59%) | 70 (60%) | 61 (57%) |
| Hospice | 12 (11%) | 11 (9%) | 9 (8%) |
Data are number (%) or mean (SD. PPS=Palliative Performance Scale.
*Two individuals (one in dignity therapy group and one in client-centred care group) did not provide an answer to the question about religious affiliation.
134 (41%) participants reported that they had lived with their life-limiting illness for less than 1 year, 104 (32%) for 1–3 years, and 88 (27%) for more than 3 years. The median survival time was 110 days (IQR <56 to <235); 213 [65%] patients had died by the time the study ended; the proportion of patients surviving in each of the study groups was not significantly different between groups (62 [57%] of in dignity therapy group, 78 [70%] of 111 in standard palliative care group, and 73 [68%] of 107 in client-centred care group; p=0·1). No difference was noted in the survival times after study completion between the three groups (81 days [IQR 48–249] in dignity therapy group, days [61–222] in standard palliative care group, and 128 days [67–233] in client-centred care group; p=0·51). Age and sex distribution, Palliative Performance Scale ratings, and dropout rate (death and withdrawal because of deterioration in health), in all three study groups showed no significant differences at completion of the study.
Because no initial threshold level of distress was stipulated as an entry criterion, the sample was most noteworthy for its paucity of distress at baseline (table 2; table 3). In most instances, patients were not greatly distressed, as indicated by the average Patient Dignity Inventory item scores and other baseline psychometric scores (table 2; table 3). Differences between before and after study measurements were calculated for Patient Dignity Inventory and Structured Interview for Symptoms and Concerns items, modified Edmonton Symptom Assessment Scale individual subscale scores, Quality of Life Scale, Functional Assessment of Chronic Illness Therapy, and Hospital Anxiety and Depression Scale; no significant differences were noted between the three groups (table 2 and table 3). The survey after the study, however, showed differences between the three study groups (table 4). Patients given dignity therapy were significantly more likely than were those in either of the two other groups to report that the treatment was helpful to them, improved their quality of life, and sense of dignity (table 4). The patients in the dignity therapy group, compared with the other study groups, were also significantly more likely to report that the study treatment changed how their family saw and appreciated them, and that it had or would be of help to their family (table 4). Dignity therapy was significantly better than the client-centred care in improving spiritual wellbeing, and was significantly better than standard palliative care in terms of lessening sadness or depression; significantly more patients who had received dignity therapy reported that the study group had been satisfactory than did those who received standard palliative care (table 4).
| Dignity therapy (n=108) | Standard palliative care (n=111) | Client-centred care (n=107) | ||||
|---|---|---|---|---|---|---|
| Baseline | Study completion | Baseline | Study completion | Baseline | Study completion | |
| Not able to continue usual routines | 2·47 (1·28) | 2·33 (1·25) | 2·70 (1·32) | 2·42 (1·25) | 2·51 (1·14) | 2·28 (1·14) |
| Physically distressing symptoms | 2·32 (1·29) | 2·37 (1·24) | 2·28 (1·21) | 2·22 (1·14) | 2·57 (1·33) | 2·35 (1·20) |
| Not able to carry out important roles | 1·88 (1·15) | 1·88 (1·24) | 2·11 (1·22) | 2·05 (1·17) | 2·02 (1·17) | 2·02 (1·17) |
| No longer feeling like who I was | 2·20 (1·29) | 2·09 (1·27) | 2·00 (1·27) | 2·02 (1·15) | 2·21 (1·34) | 2·06 (1·26) |
| Not able to perform tasks of daily living | 1·79 (1·08) | 2·11 (1·25) | 1·74 (1·15) | 1·84 (1·15) | 1·84 (1·11) | 1·88 (1·21) |
| Feeling of not having control | 2·15 (1·29) | 2·00 (1·12) | 2·08 (1·12) | 2·00 (1·05) | 2·15 (1·23) | 2·22 (1·22) |
| Feeling uncertain | 2·10 (1·18) | 2·21 (1·22) | 2·08 (1·24) | 1·88 (1·09) | 2·05 (1·16) | 2·07 (1·23) |
| Not able to attend to bodily functions | 1·42 (0·93) | 1·82 (1·56) | 1·40 (0·95) | 1·64 (1·12) | 1·56 (1·06) | 1·61 (1·02) |
| Feeling anxious | 1·93 (1·09) | 1·90 (1·09) | 1·73 (1·01) | 1·80 (1·02) | 1·93 (1·11) | 1·92 (1·08) |
| Feeling of reduced privacy | 1·82 (1·13) | 1·84 (1·18) | 1·87 (1·13) | 1·73 (1·01) | 1·66 (1·04) | 1·83 (1·08) |
| Feeling a burden to others | 1·90 (1·08) | 1·91 (1·02) | 1·99 (1·08) | 1·92 (1·11) | 2·07 (1·13) | 2·11 (1·14) |
| Feeling how you look has changed | 1·83 (1·12) | 1·72 (1·08) | 1·79 (1·11) | 1·69 (1·08) | 1·64 (1·04) | 1·71 (0·99) |
| Feeling depressed | 1·84 (1·12) | 1·81 (1·07) | 1·69 (0·95) | 1·74 (0·99) | 1·76 (1·00) | 1·76 (1·06) |
| Worried about future | 2·08 (1·30) | 2·03 (1·26) | 2·13 (1·22) | 1·76 (1·03) | 2·15 (1·24) | 1·94 (1·17) |
| Not being able to think clearly | 1·74 (0·93) | 1·79 (1·12) | 1·66 (1·04) | 1·69 (0·98) | 1·92 (1·12) | 1·85 (1·10) |
| Feeling of unfinished business | 1·91 (1·11) | 1·79 (1·02) | 1·95 (1·10) | 1·86 (1·15) | 2·03 (1·15) | 1·91 (1·07) |
| Feeling life no longer has meaning or purpose | 1·58 (0·98) | 1·46 (0·85) | 1·56 (1·05) | 1·48 (0·92) | 1⋅54 (1⋅01) | 1·64 (1·03) |
| Not feeling worthwhile or valued | 1·50 (0·93) | 1·57 (1·15) | 1·42 (0·86) | 1·44 (0·91) | 1·61 (1·09) | 1·58 (1·06) |
| Feeling have not made meaningful contribution | 1·33 (0·71) | 1·36 (0·86) | 1·30 (0·74) | 1·23 (0·67) | 1·39 (0·80) | 1·44 (0·89) |
| Not feeling able to mentally fight illness | 1·43 (0·84) | 1·46 (0·88) | 1·40 (0·79) | 1·44 (0·93) | 1·56 (0·90) | 1·58 (0·95) |
| Not being able to accept things as they are | 1·57 (1·02) | 1·54 (0·94) | 1·48 (0·86) | 1·48 (0·95) | 1⋅55 (0⋅91) | 1·50 (0·85) |
| Concerns about spiritual life | 1·30 (0·73) | 1·37 (1·26) | 1·18 (0·51) | 1·23 (0·67) | 1·36 (0·76) | 1·24 (0·61) |
| Not being treated with respect | 1·19 (0·59) | 1·20 (0·62) | 1·12 (0·40) | 1·20 (0·59) | 1·18 (0·53) | 1·23 (0·68) |
| Not feeling supported by health-care providers | 1·20 (0·68) | 1·11 (0·42) | 1·18 (0·49) | 1·13 (0·49) | 1·45 (0·95) | 1·26 (0·76) |
| Not feeling supported by friends or family | 1·23 (0·73) | 1·08 (0·39) | 1·07 (0·29) | 1·14 (0·55) | 1·18 (0·64) | 1⋅23 (0⋅71) |
Data are mean (SD). Score of 1 indicates that the treatment was not a problem, 2 a slight problem, 3 a problem, 4 a major problem, and 5 an overwhelming problem.
| Dignity therapy (n=108) | Standard palliative care (n=111) | Client-centred care (n=107) | ||||
|---|---|---|---|---|---|---|
| Baseline | Study completion | Baseline | Study completion | Baseline | Study completion | |
| Structured Interview for Symptoms and Concerns* | ||||||
| Loss of Dignity | 0·58 (1·00) | 0·67 (1·19) | 0·35 (0·81) | 0·51 (0·94) | 0·68 (1·09) | 0·47 (0·96) |
| Desire for Death | 0·44 (0·87) | 0·53 (0·88) | 0·60 (1·19) | 0·65 (1·29) | 0·64 (1·18) | 0·68 (1·18) |
| Sense of Suffering | 1·63 (1·57) | 1·34 (1·40) | 1·46 (1·53) | 1·41 (1·38) | 1·52 (1·35) | 1·52 (1·35) |
| Hopelessness | 0·90 (1·17) | 0·86 (1·27) | 0·78 (1·08) | 0·68 (1·31) | 0·87 (1·24) | 0·80 (1·17) |
| Depression | 1·22 (1·26) | 1·23 (1·23) | 1·14 (1·31) | 1·06 (1·38) | 1·25 (1·19) | 1·06 (1·25) |
| Suicidality | 0·29 (0·72) | 0·27 (0·73) | 0·21 (0·66) | 0·30 (1·02) | 0·38 (0·86) | 0·32 (0·96) |
| Burden to Others | 1·47 (1·55) | 1·33 (1·40) | 1·54 (1·45) | 1·24 (1·50) | 1·53 (1·56) | 1·43 (1·38) |
| Edmonton Symptom Assessment Scale† | ||||||
| Pain | 2·72 (2·79) | 2·79 (2·61) | 2·76 (2·80) | 2·87 (2·80) | 3·13 (2·84) | 3·18 (2·94) |
| Nausea | 1·52 (2·18) | 1·57 (2·42) | 1·62 (2·44) | 1·59 (2·61) | 1·30 (2·34) | 1·55 (2·42) |
| Drowsiness | 3·61 (2·96) | 3·65 (2·91) | 2·89 (2·71) | 3·07 (2·84) | 3·31 (2·92) | 3·54 (2·96) |
| Shortness of Breath | 1·98 (2·59) | 2·52 (2·85) | 1·70 (2·33) | 1·75 (2·50) | 2·35 (2·92) | 2·51 (3·11) |
| Will to Live‡ | 9·08 (1·94) | 8·99 (1·62) | 9·05 (2·02) | 8·84 (2·40) | 9·00 (2·00) | 9·00 (2·19) |
| Appetite | 6·59 (3·13) | 6·24 (3·04) | 5·91 (3·03) | 6·05 (3·18) | 6·93 (2·65) | 7·05 (3·00) |
| Level of Activity | 4·59 (2·97) | 4·24 (2·92) | 4·59 (2·66) | 4·45 (2·81) | 4·80 (2·69) | 4·42 (2·78) |
| Sense of Well Being‡ | 6·67 (2·67) | 6·62 (2·66) | 6·65 (2·64) | 6·44 (2·89) | 6·74 (2·62) | 6·50 (2·88) |
| Quality of life§ | ||||||
| Rating | 6·48 (2·69) | 6·39 (2·54) | 6·27 (2·70) | 6·34 (2·47) | 6·29 (2·50) | 6·64 (2·55) |
| Satisfaction | 6·34 (3·06) | 6·04 (2·94) | 6·10 (3·09) | 6·05 (2·99) | 5·83 (3·16) | 6·05 (2·88) |
| Functional Assessment of Chronic Illness Therapy (FACIT)¶ (48) | ||||||
| Total | 34·70 (9·59) | 33·97 (10·29) | 33·82 (9·56) | 34·44 (10·13) | 32·86 (9·61) | 32·43 (10·37) |
| FACIT-Secular (32) | 24·50 (5·85) | 23·88 (6·27) | 23·65 (6·30) | 24·04 (6·76) | 23·05 (6·26) | 22·80 (7·19) |
| FACIT-Faith (16) | 10·20 (5·22) | 10·09 (5·13) | 10·00 (5·07) | 10·40 (4·72) | 9·81 (5·10) | 9·63 (5·05) |
| Hospital Anxiety and Depression Scale (HADS)|| (56) | ||||||
| Total | 11·08 (6·76) | 11·45 (6·84) | 11·36 (6·76) | 11·39 (7·43) | 12·06 (7·28) | 11·76 (7·80) |
| HADS-Depression (28) | 5·86 (3·86) | 5·64 (4·07) | 6·03 (4·02) | 6·19 (4·21) | 6·30 (4·04) | 6·38 (4·30) |
| HADS-Anxiety (28) | 5·22 (4·20) | 5·81 (3·80) | 5·34 (3·79) | 5·20 (4·05) | 5·76 (4·26) | 5·38 (4·40) |
The parenthesised numbers besides the scales and subscales represent the maximum scores.
*0=none, 1=minimum, 2=mild, 3=moderate, 4=strong, 5=severe, and 6=extreme.
†1=no or poor, 10=worst.
‡Reverse scoring—higher scores represent better outcomes.
§1=poor or not satisfied, 10=excellent or very satisfied.
¶High score indicates better spiritual wellbeing.
||High score indicates more intense depression.
| Dignity therapy (n=108) | Standard palliative care (n=111) | Client-centred care (n=107) | χ²(2 df) | p value | |
|---|---|---|---|---|---|
| The study group has been helpful to me | 4·23 (0·64) | 3·50 (1·01) | 3·72 (0·89) | 35·50 | <0·0001* |
| The study group has been as helpful as any other aspect of my health care | 3·63 (1·04) | 3·27 (1·04) | 3·12 (1·04) | 6·39 | 0·041 |
| The study group has improved my quality of life | 3·54 (0·95) | 2·96 (0·96) | 2·84 (1·05) | 14·52 | 0·001* |
| The study group has given me a sense of looking after unfinished business | 3·35 (1·01) | 2·86 (1·60) | 2·93 (1·16) | 6·87 | 0·032 |
| The study group has improved my spiritual wellbeing | 3·27 (1·09) | 3·00 (1·11) | 2·56 (0·98) | 10·35 | 0·006† |
| The study group has lessened my sense of sadness and depression | 3·11 (1·02) | 2·57 (0·92) | 2·65 (1·04) | 9·38 | 0·009‡ |
| The study group has lessened my sense of feeling a burden to others | 2·81 (0·98) | 2·58 (0·95) | 2·53 (0·96) | 2·71 | 0·258 |
| The study group has made me feel more worthwhile or valued | 3·38 (0·93) | 3·35 (1·00) | 3·02 (1·01) | 3·75 | 0·153 |
| The study group has made me feel like I am still me | 3·81 (0·85) | 3·59 (0·92) | 3·40 (0·98) | 5·91 | 0·052 |
| The study group has given me a greater sense of having control over my life | 3·02 (1·02) | 3·16 (1·00) | 2·81 (1·05) | 2·74 | 0·255 |
| The study group has helped me to accept the way things are | 3·39 (1·062) | 3·31 (1·01) | 3·19 (1·12) | 0·92 | 0·630 |
| The study group has made me feel more respected and understood by others | 3·16 (0·90) | 3·04 (0·98) | 2·79 (0·98) | 3·85 | 0·146 |
| The study group has made me feel that I am still able to carry out important tasks or fill an important role | 3·62 (0·97) | 3·48 (1·00) | 3·02 (1·05) | 8·96 | 0·011 |
| The study group has been satisfactory | 4·26 (0·63) | 3·80 (0·74) | 4·17 (0·56) | 29·58 | <0·0001‡ |
| The study group has made me feel that life was more meaningful | 3·55 (1·05) | 3·19 (1·70) | 3·31 (1·02) | 6·73 | 0·035 |
| The study group has given me a heightened sense of purpose | 3·49 (1·04) | 3·20 (0·98) | 3·15 (1·03) | 6·86 | 0·032 |
| The study group has increased my sense of dignity | 3·52 (1·04) | 3·09 (1·02) | 3·11 (0·97) | 12·66 | 0·002* |
| The study group has lessened my sense of suffering | 2·86 (1·04) | 2·70 (1·02) | 2·77 (0·98) | 1·06 | 0·588 |
| The study group has increased my will to live | 2·94 (1·11) | 2·76 (1·04) | 2·92 (0·97) | 1·73 | 0·422 |
| The study group has or will be of help to my family | 3·93 (0·80) | 3·20 (1·00) | 3·29 (0·99) | 33·86 | <0·0001* |
| The study group has or could change way my family sees or appreciates me | 3·58 (1·01) | 2·85 (1·00) | 2·85 (1·04) | 33·81 | <0·0001* |
| In general, I am satisfied with my psychosocial care | 4·25 (0·77) | 4·14 (0·65) | 3·99 (0·89) | 5·97 | 0·051 |
Data are mean (SD). Score 1 is strongly disagree, 2 disagree, 3 neither agree nor disagree, 4 agree, and 5 strongly agree. NA=not applicable (detailed group comparisons only undertaken if p<0·01).
*Dignity therapy was significantly better than client-centred care and standard palliative care.
†Dignity therapy was significantly better than client-centred care.
‡Dignity therapy was significantly better than standard palliative care.
Discussion
Although floor effects precluded our ability to show significant differences between the study groups in terms of the primary outcomes, our secondary outcomes showed substantive benefits of dignity therapy, a novel psychotherapeutic approach, over standard palliative care and client-centred care. Patients in this group, when surveyed after the study, were significantly more likely to report benefits in terms of finding the treatment helpful, improving their quality of life, their sense of dignity, changing how their family saw or appreciated them, and helping their family than did those in the standard palliative care and client-centred care groups (panel 2).
Comprehensive palliative care requires that careful attention be paid to the physical, psychosocial, existential, and spiritual sources of end-of-life distress. Restricting the clinical focus on any of these domains to the exclusion of others does not achieve standards of palliative care as specified by WHO20 and the US Institute of Medicine.21 In describing factors associated with a good death, the Institute of Medicine includes preparation for death and opportunities for closure or sense of completion of the life.21 Yet, although much progress has been made in our ability to achieve physical comfort for patients who are dying, few novel interventions have been designed to address the psychosocial, existential, and spiritual dimensions of end-of-life care.
Dignity therapy was developed for the purpose of lessening distress and enhancing end-of-life experience for patients nearing death. In our phase 1 trial,6 nearly all patients reported that dignity therapy was helpful, whether they had disclosed substantial initial distress or not. On the basis of that finding, baseline distress was not specified as an entry criterion for the randomised controlled trial. Because the base rates of distress within our sample were quite low, it is perhaps unsurprising that we were unable to measure any significant changes in distress in the three study groups. Improvement in indicators of depression, will to live, and quality of life, presupposes that patients’ initially consider these a problem. In the absence of such initial distress, little room exists for improvement.
Perhaps the scales we used for assessment of our primary outcome were less responsive and less sensitive to changes than were those used for the secondary outcome, whereby patients reported their experiences in the survey undertaken after study completion. The difficulty in showing end-of-life psychosocial change with self-reported measurements has been well documented. Unlike a trial of chemotherapy, in which survival time, tumour load, and overall mortality provide readily measurable and objective outcomes, defining outcomes for dignity therapy is a greater challenge. Dignity therapy was designed to positively affect the experience of people who are dying. Measurements of overt distress, with indicators of psychosocial, existential, and spiritual effect, were incorporated into the study protocol. In a recent review of quality of life measurements that are suitable for use in palliative care, none of the items could be identified as having an established responsiveness to change.22 The conclusion drawn from the results of a meta-analysis is that distress before the intervention is a critical moderator of efficacy of psychosocial interventions in patients with cancer.23 Murray and colleagues24 have suggested that a more successful approach might be to have serial qualitative interviews. This approach, however, would not be well suited to a randomised, controlled trial.
With the lack of significant difference for the three study groups for the primary outcome measurements, we also considered whether our trial might have been underpowered. A post-hoc power calculation, based on the actual number of trial participants, determined that with 326 patients, this study had a power of 0⋅72-0⋅95 to detect an effect size of 0⋅15-0⋅30.
Patients in the dignity therapy group were significantly more likely than were those assigned to the other groups to report that this approach was helpful, improved their quality of life, enhanced their sense of dignity, and provided benefits to their family. Although they reported their initial state of psychosocial or existential wellbeing as satisfactory, patients given dignity therapy often had an enhanced quality-of-end-of-life experience that they simply could not have expected. The effect, although difficult to assess, was often poignant and profound. For example, a 72-year-old woman with bowel cancer stated that “[dignity therapy] brought to the forefront that I have to prepare my family to the best of my ability”. A 56-year-old woman said, “Mostly I want my family to know that I’m okay with dying and they must move on”. She went on to say that “the therapy showed me I am not the cancer, I am still in here. I am so grateful for that because I lost myself….it really helped me remember who I am”.
With hindsight, the argument could be that we should have screened patients for some baseline critical distress. That might have improved the likelihood of showing differences, based on changes reported in the questionnaires before and after the intervention, in the three study groups. Our disinclination to do so, however, was based on previous findings, showing the beneficial effects of dignity therapy for nearly all patients nearing death, whether overtly distressed or not. Introduction of critical thresholds of distress for study inclusion would have excluded most patients who were most likely to participate in this study. Another consideration might have been a crossover study design, in which patients could experience and thus compare dignity therapy with other possible study treatments. However, such a design would not have been feasible, with many patients either deteriorating or dying before a comparison of the groups was possible.
Notably, of the 1513 patients who were assessed for eligibility, 42% were ineligible, mainly because they were too ill to take part in the study. Of the patients who met the eligibility criteria, half consented to participate, and nearly three-quarters of these completed the protocol. For palliative care protocols that require participants who do not have any cognitive impairment, this recruitment pattern is not at all atypical.25 The nature of dignity therapy is such that only patients who are mentally capable of providing personally meaningful responses are those who will be approached to take part. Therefore, generalisability should be defined in terms of patients who maintain their cognitive capacity while they are nearing death. Although in this trial we mainly enrolled patients with cancer, the application of dignity therapy in non-cancer populations has been investigated in other studies.26
We are not aware of any instance in which patients withdrew from dignity therapy because of feeling upset or distressed. Many patients, however, indicated moments during therapy that were emotionally evocative—eg, talking about hopes or wishes for family members in anticipation of a time after their death. Mostly, however, patients appreciated the opportunity to articulate these issues. The only safety issue, which will be reported fully in a separate report of families’ experiences of dignity therapy, was that on a few occasions family members were dissatisfied with the generativity document. The family members felt the patient had become too ill to give fulsome responses, or that the answers provided a distorted image of the participant. Therefore, patients who are delirious or otherwise cognitively impaired should not be given dignity therapy.
Several studies have been done to assess dignity therapy under different circumstances. The conclusions drawn from a phase 1 Danish study27 of ten health-care professionals and 20 patients was that, with minor cultural adaptations, dignity therapy was “a manageable, acceptable and relevant intervention for Danish patients admitted to palliative care”. The results of a pilot study of eight patients in rural Kentucky, USA, with end-stage cancer showed that dignity therapy could be delivered by videophone, and achieve overall benefit and high patient satisfaction.28 In a phase 1 study of a cohort of 33 terminally ill patients that was done in French-speaking Canada, relevance and satisfaction were high for patients and their families.29
Despite the beneficial effects of dignity therapy, its ability to mitigate outright distress (eg, depression, desire for death or suicidality) has not yet been proven. Future research in more severely distressed patients might indeed establish its role in such circumstances. However, the purpose and potential benefit of individual psychotherapy for patients with advanced or terminal disease is not solely the symptomatic relief of stress.30 Psychotherapy is also offered for the prevention of distress, promotion of wellbeing, and establishment of a sense of personal meaning and life purpose. Psychotherapeutic support can help patients cope with disappointments, process the reality of leaving behind loved ones, deal with feelings of sadness, loss, isolation, and a damaged sense of identity and personal value. It can also help patients consider personal priorities in terms of relationships, religious and spiritual beliefs, and deal with the urgency of resolving conflicts or achieve personally meaningful goals.30–33 Palliative care must offer patients opportunities to engage in these complex issues, and dignity therapy is a means by which it might do so. Future research exploring the beneficial effects of dignity therapy will help to unravel the psychological, spiritual, and existential complexities for an individual facing death, and the best way to support patients with advanced and terminal illness and their families.
Acknowledgments
This study is funded by the National Cancer Institute, National Institutes of Health (grant number R01CA102201). HMC is a Canada Research Chair in Palliative Care, funded by the Canadian Institutes for Health Research. We thank our research staff, including Sheila Lander, Kathy Cullihall, Beverley Cann (Winnipeg); Joanne Hale, Jenny Clarke, Sky Dawson, and Lynn Oldham (Perth); and Shannon Poppito, Wendy Lichtenthal, Amy Berg, Kimberly Pitrelli (New York).
References
1.
Steinhauser KE, Christakis NA, Clipp EC, et al. Preparing for the end of life: preferences of patients, families, physicians, and other care providers. J Pain Symptom Manage 2001; 22: 727–37.
2.
Lynn J. Perspectives on care at the close of life. Serving patients who may die soon and their families: the role of hospice and other services. JAMA 2001; 285: 925–32.
3.
Emanuel L, Bennett K, Richardson VE. The dying role. J Palliat Med 2007; 10: 159–68.
4.
Chochinov HM, Hack T, McClement S, Harlos M, Kristjanson L. Dignity in the terminally ill: a developing empirical model. Soc Sci Med 2002; 54: 433–43.
5.
Chochinov HM. Dignity conserving care: a new model for palliative care. JAMA 2002; 287: 2253–60.
6.
Chochinov HM, Hack T, Hassard T, Kristjanson L, McClement S, Harlos M. Dignity therapy: a novel psychotherapeutic intervention for patients nearing death. J Clin Oncol 2005; 23: 5520–25.
7.
McClement S, Hack T, Chochinov HM, Hassard T, Kristjanson L, Harlos M. Dignity therapy: family member perspectives. J Palliat Med 2007; 10: 1076–82.
8.
Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry 1999; 14: 936–40.
9.
Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative Performance Scale (PPS): a new tool. J Palliat Care 1996; 12: 5–11.
10.
Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy—spiritual well-being scale (FACIT-sp). Ann Behav Med 2002; 24: 49–58.
11.
Chochinov HM, Hassard T, McClement S, et al. The Patient Dignity Inventory: a novel way of measuring dignity related distress in palliative care. J Pain Symptom Manage 2008; 36: 559–71.
12.
Moorey S, Greer S, Watson M, et al. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991; 158: 2555–59.
13.
Wilson KG, Graham ID, Viola RA, et al. Structured interview assessment of symptoms and concerns in palliative care. Can J Psychiatry 2004; 49: 350–58.
14.
Graham KY, Longman AJ. Quality of life in persons with melanoma: preliminary model testing. Cancer Nursing 1987; 10: 338–46.
15.
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991; 7: 6–9.
16.
Cohen J. Statistical power analysis for the behavioral sciences (revised edition). New York: Academic Press, 1977.
17.
Chochinov HM, Hack T, Hassard T, et al. Dignity and psychotherapeutic considerations in end of life care. J Palliat Care 2004; 20: 142–43.
18.
Chochinov HM. Dying, dignity and new horizons in palliative end-of-life care. CA Cancer J Clin 2006; 56: 84–103.
19.
Chochinov HM. Dignity therapy: final words for final days. New York: Oxford University Press (in press).
20.
WHO. Cancer pain relief and palliative care: report of a WHO Expert Committee (technical bulletin 804). Geneva: World Health Organization, 1990.
21.
Field MJ, Cassel CK. Approaching death: Improving care at the end of life. Washington DC: National Academy Press, 1997.
22.
Albers G, Echteld MA, de Vet HCW, Onwuteaka-Philipsen BD, van der Linden MHM, Deliens L. Evaluation of quality-of-life measures for use in palliative care: a systematic review. Palliat Med 2010; 24:17–37.
23.
Schneider S, Moyer A, Knapp-Oliver Sohl S, Cannella D, Targhella V. Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med 2010; 33:1–14.
24.
Murray SA, Kendall M, Carduff E, et al. Use of serial qualitative interviews to understand patients’ evolving experiences and needs. BMJ 2009; 339: b3702.
25.
Wilson KG, Chochinov HM, McPherson CJ, et al. Desire for euthanasia or physician-assisted suicide in palliative cancer care. Health Psychol 2007; 26: 314–23.
26.
Chochinov HM, Cann B, Cullihall K, et al. Dignity therapy: a feasibility study of elders in long-term care. J Palliat Support Care (in press).
27.
Houmann LJ, Rydahl-Hansen S, Chochinov HM, Kristjanson LJ, Groenvold M. Testing the feasibility of the dignity therapy interview: adaptation for the Danish culture. BMC Palliat Care 2010; 9: 21.
28.
Passik SD, Kirsh KL, Leibee S, et al. A feasibility study of dignity psychotherapy delivered via telemedicine. Palliat Support Care 2004; 2: 149–55.
29.
Gagnon P, Chochinov HM, Cochrane J, Le Moignan Moreau J, Fontaine R, Croteau L. Psychothérapie de la dignité: une intervention pour réduire la détresse psychologique chez les personnes en soins palliatifs. Psycho-Oncologie 2010; 4: 169–75.
30.
Rodin G. Individual psychotherapy for the patient with advanced disease individual psychotherapy for the patient with advanced disease. In:, Chochinov HM, Breitbart W, eds. Handbook of psychiatry and palliative medicine. New York: Oxford University Press, 2006.
31.
Cordova MJ, Cunningham LL, Carlson CR, Andrykowski MA. Posttraumatic growth following breast cancer: a controlled comparison study. Health Psychol 2001; 20: 176–85.
32.
Block SD. Perspectives on care at the close of life. Psychological considerations, growth, and transcendence at the end of life: the art of the possible. JAMA 2001; 285: 2898–905.
33.
Tedeschi RG, Calhoun LG. Trauma and the transformation of suffering. Thousand Oaks, CA: Sage Publications, 1995.
Information & Authors
Information
Published In
History
Published online: 1 October 2013
Published in print: Fall 2013
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).